Clinical Trials in Texas

Showing 1921-1940 of 12,973 trials

Crisis Response Planning in Military Personnel With Mild Traumatic Brain Injury

NCT07327567

The study purpose is to test the effect of Crisis Response Planning (CRP) when used as the second method of suicide prevention in military service members who are at risk for suicide due to mild traumatic brain injury (mTBI). CRP will be compared to usual treatment. The treatment will be a 30 to 60 minute session to one person at a time either in-person or using telehealth.

Mild Traumatic Brain InjurySuicide PreventionSuicide Risk | Patient+2 more

The University of Texas Health Science Center at San Antonio120 participantsStarted Dec 2026

Fort Hood, Texas, United States

Active Not RecruitingPhase 355 miles

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

NCT06111235

This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by surveillance for the treatment of participants with IR-NMIBC.

Non Muscle Invasive Bladder CancerUrologic CancerBladder Cancer+1 more

CG Oncology, Inc.367 participantsStarted Dec 2023

Homewood, Alabama, United States • Gilbert, Arizona, United States • Scottsdale, Arizona, United States +92 more locations

Crisis Response Planning in Military Personnel With Mild Traumatic Brain Injury

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Find Trials by Condition in Texas

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Promotion of Weight Management

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc

IC-8 Apthera IOL New Enrollment Post Approval Study

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test

A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma

A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors

Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome